Endoscopic ultrasound-guided tissue acquisition for focal liver lesions can be safely performed in patients with ascites
Endoscopy International Open · 01.11.2024 · 12 (11) · E1309-E1314
DOI: 10.1055/a-2427-2427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.11.2024. Verfasst von Yuichi Takano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims In patients with ascites, percutaneous liver biopsy is generally contraindicated. Because endoscopic ultrasound-guided tissue acquisition (EUS-TA) allows tissue sample obtention from the digestive tract lumen, a biopsy without the intervention of ascites may prevent adverse events (AEs). This study aimed to evaluate the safety of EUS-TA for focal liver lesions in the presence of ascites. Patients and methods A retrospective study was conducted using medical records of cases in which EUS-TA was performed on focal liver lesions between 2016 and 2022. Study participants were classified into two groups: those with ascites and those without it, and the outcomes were compared. The primary outcome was AEs.
Results
We included 109 cases of EUS-TA for focal liver lesions. Ascites was present in 20.1% of cases (22/109) and absent in 79.8% of cases (87/109). There were no significant differences between the two groups in clinical backgrounds and EUS-TA procedure, although fine-needle biopsy needles were significantly more frequently used in patients without ascites. In the ascites group, puncture without intervening ascites was successful in 90.9% of cases (20/22). The incidence of AEs was 4.5% (1/22) in the ascites group and 1.1% (1/87) in the non-ascites group, showing no significant difference. The two AEs were mild self-limiting abdominal pain.
Conclusions
In focal liver lesions with ascites, EUS-TA allows biopsy without the intervention of ascites in most cases. The incidence of AEs did not differ significantly between patients with and without ascites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
- Showa Daigaku Fujigaoka Byoin, Yokohama, Japan.
- Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
ORCID-Profile: Yuichi Takano, Fumitaka Niiya
Zitieren
APA
Takano, Y., Tamai, N., Yamawaki, M., Noda, J., Azami, T., Niiya, F., Nishimoto, F., Maruoka, N., Yamagami, T., & Nagahama, M. (2024). Endoscopic ultrasound-guided tissue acquisition for focal liver lesions can be safely performed in patients with ascites. Endoscopy International Open, 12(11), E1309-E1314. https://doi.org/10.1055/a-2427-2427
Vancouver
Takano Y, Tamai N, Yamawaki M, Noda J, Azami T, Niiya F, et al. Endoscopic ultrasound-guided tissue acquisition for focal liver lesions can be safely performed in patients with ascites. Endoscopy International Open. 2024;12(11):E1309-E1314. doi:10.1055/a-2427-2427
BibTeX
@article{Takano2024,
author = {Takano, Yuichi and Tamai, Naoki and Yamawaki, Masataka and Noda, Jun and Azami, Tetsushi and Niiya, Fumitaka and Nishimoto, Fumiya and Maruoka, Naotaka and Yamagami, Tatsuya and Nagahama, Masatsugu},
title = {Endoscopic ultrasound-guided tissue acquisition for focal liver lesions can be safely performed in patients with ascites},
journal = {Endoscopy International Open},
year = {2024},
volume = {12},
number = {11},
pages = {E1309--E1314},
doi = {10.1055/a-2427-2427}
}
EUVIMED